Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
atezolizumab (Tecentriq) (1 trial)
bat1308 (1 trial)
bat6026 (1 trial)
bld-2660 (1 trial)
bsi-045b (1 trial)
Cudetaxestat (1 trial)
entecavir (baraclude) (1 trial)
hec88473 (1 trial)
hemay005 (1 trial)
imiglucerase (cerezyme) (1 trial)
interferon alpha-2a (roferon-a) (1 trial)
kf-0210 (1 trial)
lactobacillus plantarum (1 trial)
rbd1016 (1 trial)
tebipenem (1 trial)
tnm002 (1 trial)
Upleganan (1 trial)
Vonafexor (1 trial)
Fibrosis (Phase 1)
Hepatitis B (Phase 1)
Hepatitis B, Chronic (Phase 1)
Trials (14 total)
Trial APIs (18 total)